Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sjors Van Klaveren

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
RSC Advances|July 25, 2022
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitorsSjors van Klaveren, Jaka Dernovšek, Žiga Jakopin, et al.
Chemmedchem|December 16, 2021
Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-GalactalsSjors van Klaveren, Anders P Sundin, Žiga Jakopin, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique PocketSjors van Klaveren, Mujtaba Hassan, Maria Håkansson, et al.
Chemmedchem|October 6, 2021
Selective Monovalent Galectin-8 Ligands Based on 3-LactoylgalactosideBenedetta Girardi, Martina Manna, Sjors Van Klaveren, et al.
European Journal of Medicinal Chemistry|July 5, 2021
Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisationMujtaba Hassan, Sjors van Klaveren, Maria Håkansson, et al.
Frontiers in Chemistry|February 8, 2021
Discovery of Diaryl Ether Substituted Tetrahydrophthalazinones as TbrPDEB1 Inhibitors Following Structure-Based Virtual ScreeningErik de Heuvel, Albert J Kooistra, Ewald Edink, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
RSC Advances|July 25, 2022
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitorsSjors van Klaveren, Jaka Dernovšek, Žiga Jakopin, et al.
Chemmedchem|December 16, 2021
Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-GalactalsSjors van Klaveren, Anders P Sundin, Žiga Jakopin, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique PocketSjors van Klaveren, Mujtaba Hassan, Maria Håkansson, et al.
Chemmedchem|October 6, 2021
Selective Monovalent Galectin-8 Ligands Based on 3-LactoylgalactosideBenedetta Girardi, Martina Manna, Sjors Van Klaveren, et al.
European Journal of Medicinal Chemistry|July 5, 2021
Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisationMujtaba Hassan, Sjors van Klaveren, Maria Håkansson, et al.
Frontiers in Chemistry|February 8, 2021
Discovery of Diaryl Ether Substituted Tetrahydrophthalazinones as TbrPDEB1 Inhibitors Following Structure-Based Virtual ScreeningErik de Heuvel, Albert J Kooistra, Ewald Edink, et al.
Pageof 1